Records containing: Recurrent Glioblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase II, Multi-site, Open-label Trial Evaluating the Safety and Efficacy of Pumitamig and Bevacizumab as Monotherapy and Pumitamig in Combination With Temozolomide in Patients With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-03-11Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
-
CLINICAL_TRIALS study record update · 2026-03-09A Phase I Study of RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
-
CLINICAL_TRIALS study record update · 2026-03-05Phase I Clinical Trial of Allogeneic Bone Marrow Human Mesenchymal Stem Cells Loaded With A Tumor Selective Oncolytic Adenovirus, DNX-2401, Administered Via Intra-Arterial Injection in Patients With Recurrent High-Grade Glioma
-
CLINICAL_TRIALS study record update · 2026-03-05Phase Ib Open-label Study of Adjuvant CUE-102, a WT-1-pHLA-IL2-Fc Fusion Protein in Glioblastoma (GBM) Patients at First Recurrence
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04A Surgical "Window-of-Opportunity" and Phase II Trial of Pembrolizumab, Olaparib and Temozolomide in Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-03-04A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
-
CLINICAL_TRIALS study record update · 2026-02-23MC240704 Pilot Dose Escalation and Expansion Study of Sonodynamic Therapy With Aminolevulinic Acid Hydrochloride (5-ALA HCl Or SONALA-001) in Combination With Exablate 4000 Type 2.0 MR-Guided Focused Ultrasound (MRgFUS) in Patients With Progressive or Recurrent Glioblastoma Multiforme (RGBM)
-
CLINICAL_TRIALS study record update · 2026-02-23Window of Opportunity Assessment of [Fam-]Trastuzumab DERuxtecan-nxki (T-DXd) Brain Tumor Penetration and Efficacy (WOnDER-BT)
-
CLINICAL_TRIALS study record update · 2026-02-12Pilot Study Testing Feasibility of Individualized Therapy for Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-02-09A Phase 1-2 Dose-escalation and Expansion Study of ST101 in Patients With Advanced Unresectable and Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-04INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs With GBM
-
CLINICAL_TRIALS study record update · 2026-01-20Assessment of Safety and Feasibility of Exablate Blood-Brain Barrier Disruption (BBBD) With Microbubbles for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy
-
CLINICAL_TRIALS study record update · 2026-01-14A Phase 1/1b Adaptive Dose Escalation Study of Mycophenolate Mofetil (MMF) in Combination With Standard of Care for Patients With Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-01-08A Phase II Study Evaluating the Efficacy and Safety of Niraparib and Tumor-Treating Fields in Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-01-07OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
-
CLINICAL_TRIALS study record update · 2026-01-07Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM
-
CLINICAL_TRIALS study record update · 2025-12-19Phase I/II Study to Evaluate the Safety and Clinical Efficacy of Atezolizumab (Anti-PD-L1) in Combination With Cabozantinib in Patients With Recurrent Glioblastoma (rGBM)
-
CLINICAL_TRIALS study record update · 2025-12-15A Single-Dose Study of Orally Administrated Defactinib or VS-6766 in Patients With Glioblastoma
-
CLINICAL_TRIALS study record update · 2025-12-12Phase Ib, Open-Label Study of CART-EGFR-IL13Rα2 Cells Administered Following Lymphodepleting Chemotherapy or Prior to Surgical Resection in Patients With EGFR-Amplified Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2025-11-28Pilot Study to Evaluate Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI Methods at 7Tesla Metabolic Profiling of Glioblastoma
-
CLINICAL_TRIALS study record update · 2025-11-18An Open-label, First-in-human, Dose-escalation and Dose-expansion, Phase I Study of Fully Human B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy for Treatment of Recurrent or Refractory Glioblastoma
-
CLINICAL_TRIALS study record update · 2025-11-13Phase 0/I Study of AMG 232 (KRT 232) Concentrations in Brain Tissue in Patients With Recurrent Glioblastoma and of AMG 232 (KRT 232) in Combination With Radiation in Patients With Newly Diagnosed Glioblastoma and Unmethylated MGMT Promoters
-
CLINICAL_TRIALS study record update · 2025-11-10Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM
-
CLINICAL_TRIALS study record update · 2025-11-03A Phase 1 Study of Bispecific T Cell Engager (BRiTE) in Patients With Newly Diagnosed or Recurrent Glioblastoma